Rubin Eyal 4
4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Nov 20, 2017
Insider Transaction Report
Form 4
Rubin Eyal
CFO and Treasurer
Transactions
- Award
Common Stock
2017-11-20+25,000→ 25,000 total - Award
Stock Option (right to buy)
2017-11-20+93,686→ 93,686 totalExercise: $4.30From: 2018-11-20Exp: 2027-11-20→ Common Stock (93,686 underlying)
Footnotes (2)
- [F1]Shares acquired are shares of restricted stock awarded on November 20, 2017 under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock vest as to 100% of the award on April 1, 2018, provided that the Reporting Person remains continuously employed by Brainstorm Cell Therapeutics Ltd. from the date of grant through the vesting date.
- [F2]Option shall vest and become exercisable as to 25% of the underlying shares on each of the first, second, third and fourth anniversary of the date of grant, until fully vested and exercisable on the fourth anniversary of the date of grant, provided Reporting Person remains employed by Brainstorm Cell Therapeutics Ltd. from the date of grant through each applicable vesting date.